Ask a question about this product
The present Competitive Intelligence report about HIV Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines against human immunodeficiency virus (HIV). Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of currently active projects in research and development for prophylaxis and therapy of human immunodeficiency virus (HIV) infection. In addition, the report lists company-specific R&D pipelines of HIV vaccines. Competitor projects are listed in a tabular format providing information on:
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Product Category,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
- DNA vaccines (plasmid, conventional, alternative delivery and prime – boost regimens)
- Adenoviral vector vaccines
- Poxvirus vector vaccines
- Protein & peptide vaccines
- Corporate HIV Vaccine R&D Pipelines
About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.